Aralez sales and marketing update

Aralez launched once-daily Yosprala 325/40 ( PA32540) and Yosprala 81/40 ( PA8140) in the U.S. for the secondary prevention of cardiovascular disease in patients at risk for aspirin-induced gastric ...